Literature DB >> 2199593

The role of carnitine in intracellular metabolism.

J Bremer1.   

Abstract

In animal cells long chain fatty acids are transferred into the mitochondria for oxidation as acylcarnitines. Carnitine palmitoyltransferase I in the outer membrane, and carnitine translocase plus carnitine palmitoyltransferase II in the inner membrane catalyse the transfer. Carnitine palmitoyltransferase I is inhibited by malonyl-CoA, an intermediate in fatty acid synthesis. In the liver of fasted, diabetic, or thyreotoxic animals this enzyme shows increased activity and less inhibition by malonyl-CoA. Peroxisomes also contain carnitine acyltransferases and a beta-oxidation enzyme system. This system is particularly active in the shortening of very long chain fatty acids. The carnitine acyltransferases of the peroxisomes presumably are active in the transfer of the shortened acyl-CoAs and the acetyl-CoA to the mitochondria for complete oxidation. The carnitine acyltransferases of the mitochondria can catalyse the formation of propionylcarnitine and branched chain acylcarnitines from branched chain amino acids, and methylthiopropionylcarnitine from methionine. Their formation may represent a "security valve" preventing acyl-CoA accumulation in the mitochondria. The liver, which normally releases carnitine for other tissues, releases the branched chain acylcarnitines even more easily. This may be important for the development of secondary carnitine deficiency in some inborn errors of metabolism which are accompanied by the accumulation of acyl-CoAs in the tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199593

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  17 in total

Review 1.  Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Authors:  Mike Youle
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Modulating carnitine levels by targeting its biosynthesis pathway - selective inhibition of γ-butyrobetaine hydroxylase.

Authors:  Anna M Rydzik; Rasheduzzaman Chowdhury; Grazyna T Kochan; Sophie T Williams; Michael A McDonough; Akane Kawamura; Christopher J Schofield
Journal:  Chem Sci       Date:  2014-05-01       Impact factor: 9.825

Review 3.  Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?

Authors:  G Moyle
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

4.  Post-treatment with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injury.

Authors:  Juan-Pablo Idrovo; Weng-Lang Yang; Akihisa Matsuda; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2012-01       Impact factor: 3.454

5.  In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine.

Authors:  Su Xu; Jaylyn Waddell; Wenjun Zhu; Da Shi; Andrew D Marshall; Mary C McKenna; Rao P Gullapalli
Journal:  Magn Reson Med       Date:  2014-12-02       Impact factor: 4.668

6.  Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants.

Authors:  S Vijay; A Patterson; S Olpin; M J Henderson; S Clark; C Day; G Savill; J H Walter
Journal:  J Inherit Metab Dis       Date:  2006-07-23       Impact factor: 4.982

Review 7.  Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.

Authors:  G J Moyle; M Sadler
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

8.  L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies.

Authors:  S Chiechio; A Copani; F Nicoletti; R W Gereau
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

9.  Mitochondrial involvement in sensory neuronal cell death and survival.

Authors:  Pavlos C Englezou; Mauro Degli Esposti; Mikael Wiberg; Adam J Reid; Giorgio Terenghi
Journal:  Exp Brain Res       Date:  2012-07-24       Impact factor: 1.972

10.  Transient carnitine transport defect with cholestatic jaundice: report of one case in a premature baby.

Authors:  Hyun-Seok Cho; Young Kwang Choo; Hong Jin Lee; Hyeon-Soo Lee
Journal:  Korean J Pediatr       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.